Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Cascales Campos PA, Gonzalez-Gil A, Gomez-Ruiz AJ, Gil-Gomez E, Alconchel-Gago F, Navarro-Barrios A, Martinez-Garcia J, Alonso-Romero JL, Nieto A, Barcelo-Valcarcel F, Gil-Martinez J. Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies. Hernia. 2020 Apr;24(2):257-263. doi: 10.1007/s10029-019-01962-4. Epub 2019 May 8. PubMed PMID: 31069579.
AÑO: 2020; IF: 2.92
31069579
Perez-Garcia, JM; Llombart-Cussac, A; Holgado, E; Curigliano, G; Miranda, EL; Alonso-Romero, JL; Bermejo, B; Calvo, L; Caranana, V; Sanchez, SD; Cortes, MG; Vazquez, RM; Prat, A; Borrego, MR; Sampayo, M; Segui, MA; Soberino, J; Malfettone, A; Schmid, P; Cortes, J. A phase II study of pembrolizumab and eribulin in patients with HR-positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes (KELLY study). CANCER RESEARCH. 2020; 80(4). 10.1158/1538-7445.SABCS19-P3-09-03
AÑO: 2020; IF: 12.701
Sureda M, Mata JJ, Catalan A, Escudero V, Martinez-Navarro E, Rebollo J. Therapeutic drug monitoring of nivolumab in routine clinical practice. A pilot study. Farm Hosp. 2020 Apr 17;44(3):81-86. doi: 10.7399/fh.11319. PubMed PMID: 32452306.
AÑO: 2020
32452306
Todo, FR; Stradella, A; Garcia-Saenz, JA; De Las Heras, BB; Romero, JLA; Barnadas, A; Peron, YI; Alba, E; Lopez-Tarruella, S; Henao-Carrasco, F; Carrasco, E; Caballero, R; Del Campo, M. Unraveling trastuzumab emtansine resistance in HER2-positive advanced breast cancer: GEICAM KATIA study. ANNALS OF ONCOLOGY. 2020; 31:S391-S391. 10.1016/j.annonc.2020.08.456
AÑO: 2020; IF: 32.976
Jose JM, Jose M, Silverio R, Federico V, Isabel C, Martin OA, Inmaculada B, Cristina C, Julia HC, Dolores TM, Jose G, Paola P, Nieves DP, Vicent A, Sara B, Sara M, Julian L, Manuel S, Del Carmen MM, Angel CM, Vicente G. Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma. Clin Transl Oncol. 2020 Sep;22(9):1517-1523. doi: 10.1007/s12094-020-02288-9. Epub 2020 Feb 11. PubMed PMID: 32048159.
AÑO: 2020; IF: 3.34
32048159
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL